The Healthspan Action Coalition (HSAC) today announced a strategic international collaboration with a coalition of prominent Italian organizations, including Fondazione Bicocca, Italian Sources for Healthspan and Saturnia Healthy Longevity, Palazzo Fiuggi, Columbus Clinic Center, Tennis & Friends, Women Economic Forum Italy, BrainCircle Italy, AEON Foundation, and The Cure Alliance (Italy Healthspan Initiative), to advance scientific innovation, public understanding, policy engagement, and practical action aimed at extending healthy human life.

Through the new collaboration, HSAC and its Italian partners are creating a platform for cooperation across longevity and aging science, regenerative medicine, preventive health, education, convening, and public-policy dialogue. The alliance will connect investigators, clinicians, entrepreneurs, patient advocates, universities, foundations, women’s leadership networks, and public institutions in both countries and internationally.

Spearheaded by Camillo Ricordi, M.D., HSAC Chief Scientific Officer, the initiative connects scientific, civic, philanthropic, and institutional leaders around a shared global healthspan agenda. The collaboration reflects HSAC’s mission to deliver extended healthspan across the world.

“The science is moving rapidly toward a new paradigm: intervening earlier to identify invisible risk factors years before they progress toward disease, preserving function and preventing chronic illness by fully integrating predictive and preventive strategies. This will reduce the overburdening of a reactive health system already straining in the face of worldwide aging populations,” said Ricordi.

“This collaboration couldn’t come at a more urgent time,” said Bernard Siegel, JD, co-founder and executive director of HSAC. “It dovetails with our goal of improving the healthspan for all people, regardless of race, gender, geography or socioeconomic level. Nations across the globe need unprecedented measures to circumvent the potential social, humanitarian and economic problems of the coming aging tsunami by ensuring that health and vitality are achievable well into the older years.”

Marco Peronaci, the Italian Ambassador to the United States, said, “I am particularly pleased to see Italian scientific and civil-society organizations joining forces with their American partners in an initiative that places prevention, scientific evidence and international cooperation at its core.”

The initiative will be formally announced during the opening program of the Translational Longevity Summit in Boston, where Giovanna Iannantuoni, President of Fondazione Bicocca and a leader in academic, cultural, and international engagement, will deliver opening remarks recognizing the importance of an expanded Italy-United States partnership for healthspan. The upcoming Summit will take place October 7 - 11 at Harvard University’s new Enterprise Research Center in Boston, MA.

“Our overarching mission requires collaboration across disciplines, institutions, and national borders. This Italy-HSAC initiative is designed to bring scientific excellence together with public leadership, education, and implementation, so that advances in regenerative medicine, prevention, and longevity science can benefit people around the world,” said Iannantuoni.

A cross-border platform for healthspan

The partners will explore joint activities that may include:

• International forums, conference programming, and expert exchanges on healthy aging, longevity science, regenerative medicine, and prevention.
• Public education initiatives that communicate evidence-based approaches to healthspan in accessible language.
• Connections among researchers, clinicians, academic institutions, foundations, policymakers, patient advocates, and responsible innovators.
• Dialogue on policy, investment, and health-system strategies that support disease prevention, functional independence, and equitable access to emerging healthspan advances.
• Opportunities to elevate women’s leadership, intergenerational engagement, and cross-sector participation in shaping the future of health and longevity.

“This is a historic moment in the field of healthspan,” said Siegel. “We’re deeply honored to be working with some of Italy’s most prominent health and longevity organizations on our shared goals for the good of people everywhere.”

An official part of Boston Longevity Week, the Translational Longevity Summit is produced under the Boston BioLife umbrella in collaboration with the Healthspan Action Coalition, World Stem Cell Summit and Regenerative Medicine Foundation. 

About The Healthspan Action Coalition

The Healthspan Action Coalition is a nonprofit, cross-sector coalition advancing “Healthspan for All”: More years of health, independence and dignity for all people through science, policy, patient advocacy and collaboration. Visit healtspanaction.org and translationallongevity.com to learn more about the Translational Longevity Summit 2026.

MEDIA CONTACT

Joseph Dawson

Director of Communications, HSAC

Email Contact

Tel. +1 561-906-4755

Bernard Siegel, JD

Executive Director, HSAC

Email Contact

Tel. +1 305 801 4928

Scientific inquiries

Camillo Ricordi, MD

Chief Scientific Officer, HSAC

Email Contact

Tel. +1 305 582 7151

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Eleven years after Boston BioLife was established to help bridge the gap between emerging science and clinical medicine, the organization will bring that founding mission to a larger stage as co-presenter of the Translational Longevity Summit, taking place October 7-11, 2026, at Harvard’s Enterprise Research Campus in Boston.

Presented by Boston BioLife and the Healthspan Action Coalition as part of Boston Longevity Week, the five-day summit will convene leaders from science, medicine, technology, patient advocacy, policy and investment to examine how promising discoveries can be responsibly evaluated, translated and advanced toward meaningful clinical application.

Founder Joseph P. Krieger views the summit as a pivotal milestone for Boston BioLife's mission started in July 2015.

“When I founded Boston BioLife, the goal was to help physicians understand emerging science and determine how it could responsibly contribute to better patient care,” said Krieger. “Eleven years later, this summit gives us the opportunity to expand that conversation across the entire translational ecosystem-from researchers and clinicians to patients, policymakers and investors.”

Krieger’s path to Boston BioLife began with an education in biochemistry and a career in medical-device technology and physician training. While creating educational programs around radiofrequency ablation and other medical technologies, he recognized that successful clinical adoption required more than introducing a new device or discovery. Healthcare professionals needed to understand the underlying science, appropriate applications, limitations, regulatory considerations and patient-safety implications.

That realization became the foundation of Boston BioLife.

In a 2016 BioInformant interview, Krieger described the organization’s purpose as facilitating the understanding of life-science technologies in clinical medicine and helping move innovation from “bench to bedside.” He emphasized the importance of accurate research, regulatory awareness and patient safety-principles that continue to inform Boston BioLife’s educational mission today.

The Translational Longevity Summit extends that work into the rapidly evolving field of longevity. Discussions will explore aging, healthspan, regenerative medicine, personalized care and the scientific and practical challenges involved in moving new discoveries from research environments into responsible real-world use.

The summit will also emphasize cross-sector collaboration. Researchers, physicians, industry leaders, technology developers, patient advocates, policy voices and investors each play a role in determining how emerging science is studied, funded, regulated, understood and ultimately made accessible.

Patient participation will be an important part of that conversation. People living with illness and age-related conditions bring essential perspectives on urgency, daily function, treatment burden and unmet needs. Their involvement can help ensure that research, education and innovation remain connected to the people medical progress is intended to serve.

“Translation does not happen within a single laboratory, company or medical practice,” Krieger added. “It requires researchers, clinicians, patients, regulators, advocates and responsible industry partners to ask better questions together. That is the community we are bringing together in Boston.”

For a Massachusetts native who built his career near Boston’s medical, academic and scientific institutions, holding the summit at Harvard’s Enterprise Research Campus carries particular significance. The location brings Boston BioLife’s original educational mission into an environment created to encourage research, innovation and collaboration.

Eleven years after its founding, Boston BioLife’s purpose remains consistent: to help the healthcare community understand emerging science and evaluate its potential relevance to patient care.

In October, that enduring mission will bring a broader community together in Boston to address one of longevity medicine’s most important challenges: translating scientific promise into responsible, measurable progress.

Translational Longevity Summit

October 7-11, 2026
1 Milestone Street and the Atlas Hotel
Harvard Enterprise Research Campus
Boston, Massachusetts

Presented by Boston BioLife and the Healthspan Action Coalition

Event information and registration: https://translationallongevity.com/

About Boston BioLife

Founded in July 2015, Boston BioLife provides educational programs designed to help physicians and scientists understand emerging developments in regenerative and translational medicine. Its programming brings together scientific research, clinical education, regulatory awareness and patient-safety considerations to support informed evaluation of developing medical technologies.

Learn more at https://bostonbiolife.com/.

About the Healthspan Action Coalition

The Healthspan Action Coalition is a cross-sector organization working to advance medical strategies, research, public policy and collaboration focused on improving healthspan and addressing age-related disease.

Learn more at https://healthspanaction.org/.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

The Functional Longevity Summit Dallas 2026, hosted by Boston BioLife, will take place May 15-17, 2026 at the Hilton Anatole, convening physicians, clinicians, and healthcare innovators at the intersection of precision medicine, regenerative therapies, and practice optimization.

This three-day medical education event showcases the latest longevity science advancements and equips providers with actionable strategies to enhance patient outcomes and business performance.

The Functional Longevity Summit introduces a new model for medical conferences, offering a clinical and operational training environment, unlike traditional biohacking events.

The focus extends beyond exposure to new technologies and therapies. It emphasizes:

• Practical implementation in real-world clinical settings
• Revenue and profit optimization for longevity-focused practices
• Integration of multiple modalities into cohesive treatment systems

Featured Experts and Innovators

The Dallas 2026 summit is expected to include contributions from leading voices in longevity science and clinical innovation, including:

• Dr. Aimee Duffy

• Dr. Bill Andrews

• Dr. Jeffrey Gross

These experts represent a range of disciplines across functional medicine, regenerative therapies, and advanced longevity research.

Participating Brands and Technologies

The summit is also expected to feature companies and solution providers across the longevity and regenerative medicine ecosystem, including:

• Kimera Labs
• Life Armour
• OxyHealth
• Regenerative Lifespan
• Mavrix Profit System

These organizations reflect a broader shift in the industry: combining clinical innovation with scalable business infrastructure.

Key Clinical and Business Topics

The summit's curriculum covers high-impact areas in medicine and practice growth: Advanced Diagnostics, Personalized Therapies, Regenerative Medicine, Energy-Based Modalities, and Practice Integration.

Many providers are exposed to technologies without clear guidance on:

• How to integrate them into workflows
• How to combine modalities effectively
• How to build a financially sustainable model

The Functional Longevity Summit aims to address that gap directly.

Who Should Attend

• Physicians, nurse practitioners, and physician assistants
• Functional and integrative medicine practitioners
• Longevity and anti-aging specialists
• Clinic owners and healthcare entrepreneurs

Event Details

Event: Functional Longevity Summit Dallas 2026
Dates: May 15-17, 2026
Location: Hilton Anatole, Dallas, TX
Host: Boston BioLife
Website: https://dallas.regenmedworkshops.com 

About the Functional Longevity Summit

The Functional Longevity Summit is a practitioner-focused educational platform advancing precision, functional, and regenerative medicine through immersive, hands-on training. By combining clinical education with real-world implementation and business strategy, the summit is designed to help providers translate innovation into measurable patient outcomes and scalable practice growth.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

The conversation around aging is rapidly changing, and Boston BioLife is placing Phoenix at the center of that transformation.

From February 27 through March 1, Boston BioLife will convene an exclusive, three-day Functional Longevity Medicine Summit, gathering leading clinicians, scientists and health innovators for what organizers describe as a working summit focused on the real-world future of precision-based care.

Unlike traditional medical conferences, this immersive event is designed to move beyond theory and into actionable clinical and business strategies shaping the next era of preventive and personalized medicine.

Inside the Longevity Playbook

With longevity medicine accelerating at an unprecedented pace, the summit will spotlight four critical pillars driving the field forward:

• The molecular science behind aging and cellular decline
• Advanced functional diagnostics guiding modern clinical decisions
• Breakthrough therapeutic strategies translating science into patient outcomes
• Sustainable business models for longevity-focused medical practices

More than 100 forward-thinking medical and wellness professionals are expected to attend as they seek to stay ahead in one of healthcare’s fastest-evolving sectors.

Powerhouse Voices Take the Stage

The summit features an impressive lineup of respected thought leaders, including:

• Dr. Kien Vuu, physician and longevity expert
• Bill Andrews, pioneering telomere researcher
• Brian Bradley, performance strategist known for work with Tony Robbins
• Patrick Porter, founder of BrainTap and neurotechnology innovator
• Amie Hornaman, thyroid and metabolic health specialist

Exhibitors will showcase cutting-edge technologies and therapeutics, including therapeutic plasma exchange programs from Lifespan Edge, alongside solutions from Life Armor, Pneuma Nitric Oxide, InHale and Integrative Peptides.

Media Attention and Community Impact

National and niche outlets including NDNR.com, the Next Generation Podcast Network, the Biohacking Index and Top Doctor Magazine are slated to cover the gathering, along with regional media.

The event has also attracted former NFL player and entrepreneur AC Caswell, founder of Million Dollar Mingle Celebrity Charity Events. In partnership with Project One Cause, the summit will support charitable initiatives benefiting Scottsdale-area communities.

A Shift from Sick Care to Smart Care

Joseph Krieger, founder and CEO of Boston BioLife says “This summit reflects a larger healthcare inflection point, as providers increasingly pivot from reactive treatment models toward proactive, data-driven longevity strategies.”.

Clinicians and industry professionals interested in attending can learn more and secure tickets through BostonBioLife.com - and stay tuned for the Spring Functional Longevity Summit in Washington D.C (tentitively set for June 4th - 7th, 2026).

About Boston BioLife

Boston BioLife is a professional education and marketing platform serving the longevity, functional medicine and regenerative health communities. Through events, media and practitioner-focused initiatives, the company connects clinicians and solution providers working at the forefront of personalized health optimization.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.